Mylan's half-priced EpiPen will hit pharmacies next week

The EpiPen generic Mylan promised in August amid a pricing firestorm is officially on its way to market.The product—priced at $300 per two-pack, less than half the branded med’s list price—will hit pharmacy shelves next week, Mylan said.The EpiPen copycat is a solution Mylan pledged after Congressional questions about its pricing—which has gone from $100 in 2008 to more than $600—ignited public outcry. Industry watchers, including Wells Fargo analyst David Maris, labeled the copay assistance Mylan first offered up as a “good start” but “not enough,” prompting the company to go a step further.The generic announcement didn’t exactly put out the flames, though, especially considering the later revelation that Mylan had misclassified the epinephrine auto-injector as a generic—subject to lower Medicaid rebates—rather than an “innovator” drug as it should have been.